HIV I Infection research hub

A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/

This study looks at how well a new HIV medication called Doravirine (DOR) works for people living with HIV in Europe. It checks if the treatment helps, if people stop using it, and if the virus becomes resistant over 12 months.